After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, TERN falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Terns Pharmaceuticals Inc is $275.11M. A total of 0.84 million shares were traded on the day, compared to an average of 1.09M shares.
In the most recent transaction, Kuriakose Emil sold 952 shares of TERN for 2.49 per share on Apr 01 ’25. After the transaction, the Chief Medical Officer now owns 53,317 company shares. In a previous transaction on Nov 30 ’24, Jung Melita Sun bought 2,250 shares at 5.11 per share. TERN shares that Chief Business Officer owns now total 2,250.
Among the insiders who bought shares, Burroughs Amy L. acquired of 510 shares on Nov 30 ’24 at a per-share price of $5.11. This resulted in the Chief Executive Officer holding 19,609 shares of TERN after the transaction. In another insider transaction, Kuriakose Emil sold 4,481 shares at $5.71 per share on Jan 02 ’25. Company shares held by the Chief Medical Officer now total 54,269.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, TERN has a high of $11.40 and a low of $1.87.
As of this writing, TERN has an earnings estimate of -$0.29 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.31.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. TERN’s latest balance sheet shows that the firm has $165.98M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $6.82M in liabilities at the time. Its Book Value Per Share was $3.73, while its Total Shareholder’s Equity was $160.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
